Guardian Pharmacy Services, Inc.: stock overview

GRDNNYSEConsumer defensive · Retail-Drug Stores and Proprietary Stores

Price

$49.52

November 13, 2026Market cap $3.1B

DCF calculator

What Ploutos Investor adds for Guardian Pharmacy Services

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 2 fiscal years, from 2024
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has risen 24% since Nov 5, 2026, when the 10-Q these figures come from was filed ($39.87 then, $49.52 on Nov 13, 2026). The figures date from before that move.10-Q

In short

Guardian Pharmacy Services had revenue of $1.5B over the last 12 months and net income of $75M, a net margin of 5.1%. At $49.52 the shares trade at a P/E of 42.0. It holds more cash than debt, by $120M. It pays no dividend.

From its SEC filings (latest fiscal year to December 31, 2025) and the price of November 13, 2026.

Its SEC filings
Market cap
$3.1B
63.35M shares
P/E
42.0
Revenue, 12 months
$1.5B
+17.9% a year over 1 years
Net margin
5.1%
2025: 3.4%, above 67% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

2 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

2024–2025 fiscal years
  • 202510-K
    Revenue$1.4B
  • 202410-K
    Revenue$1.2B

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 
$3.1B
Enterprise value 
$3.0B
P/E 
42.0
EV / EBIT 
32.1
EV / Revenue 
2.1
P/B 
11.2
FCF yield 
2.8%
Earnings yield 
2.4%

Profitability

Gross margin 
22.5%
Operating margin 
6.5%
Net margin 
5.1%
ROIC 
28.8%
ROIC, 5-year average 
-3.4%
ROE 
31.6%

Growth

Revenue, yearly change 
+17.9%
EPS, yearly change 
–
FCF, yearly change 
+100.8%
Revenue, average a year 
+17.9%

The yearly change compares FY2025 with FY2024.

Balance sheet

Cash 
$120M
Total debt 
$36M
Of which operating leases 
$36M
Net cash 
$120M
Net debt / EBITDA 
-1.0x
Interest cover 
145.3x
Current ratio 
1.65

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
–
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 59).

Gross margin

20.2%

Above 15% of the 51 companies in its industry, and 22% of all.

Operating margin

5.0%

Above 73% of the 65 companies in its industry, and 50% of all.

Net margin

3.4%

Above 67% of the 66 companies in its industry, and 46% of all.

ROE

22.6%

Above 84% of the 46 companies in its industry, and 86% of all.

ROA

11.9%

Above 90% of the 64 companies in its industry, and 91% of all.

Revenue growth

17.9%

Above 90% of the 66 companies in its industry, and 78% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
Guardian Pharmacy Services, Inc.
CIK
1802255
Exchange
NYSE
Industry (SIC)
5912 · Retail-Drug Stores and Proprietary Stores
Fiscal year ends
December 31
Latest annual report
December 31, 2025
Reporting currency
USD
Shares
63.35M

Other companies: Consumer defensive

The largest companies of the same sector, each with its own page.

The Consumer defensive sectorAll companies

The full analysis

What do Guardian Pharmacy Services's filings show?

These are Guardian Pharmacy Services's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about GRDN

Didn't find what you were looking for?

Ask us
What is GRDN's market cap?

Guardian Pharmacy Services, Inc.'s market cap is $3.1B, at a price of $49.52 on November 13, 2026 and 63.35M shares.

What is GRDN's P/E?

GRDN's P/E is 42.0, on earnings per share of $1.18 over the last 12 months.

How much revenue does GRDN have?

Guardian Pharmacy Services had revenue of $1.5B over the last 12 months. Over the last 1 years it changed by +17.9% a year on average.

Does GRDN pay a dividend?

No. Guardian Pharmacy Services paid no regular dividend over the last 12 months.

Where do the figures come from?

From Guardian Pharmacy Services, Inc.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.